NCT01187199 2026-04-16
Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
Clinical Trials
2,025 trialsNCT04879121 2026-04-16
Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07326800 2026-04-16
MAEva-MCT
Institut de Cancérologie de Lorraine
Phase NA Recruiting
NCT02387905 2026-04-15
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03671226 2026-04-15
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04452825 2026-04-15
A New Psychotherapy Intervention for Older Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT04957615 2026-04-15
Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05347212 2026-04-15
Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06669572 2026-04-15
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
University of Chicago
Phase 2 Recruiting
NCT07528547 2026-04-15
Peds Ethos
University Health Network, Toronto
Phase NA Recruiting
NCT01642017 2026-04-14
VOTRAGE
Institut Claudius Regaud
Phase 1 Terminated
NCT02857400 2026-04-14
CREDO
Institut Claudius Regaud
Phase NA Completed
NCT03768336 2026-04-14
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
Massachusetts General Hospital
Phase NA Active not recruiting
NCT03956459 2026-04-14
IQversusMI
Institut Claudius Regaud
Phase NA Completed
NCT05088395 2026-04-14
ALCINA4
Institut Curie
Phase NA Recruiting
NCT05821556 2026-04-14
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
National Cancer Institute, Naples
Phase 2 Recruiting
NCT04520711 2026-04-13
Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
Providence Health & Services
Phase 1 Active not recruiting
NCT05465161 2026-04-13
StingMark
Centre hospitalier de l'Université de Montréal (CHUM)
Phase NA Recruiting
NCT05879146 2026-04-13
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06319378 2026-04-13
CAPSI
Section for Affective Disorders; Northern Stockholm Psychiatry
Phase 2 Recruiting
NCT06609473 2026-04-13
CHEF
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT06763770 2026-04-13
Digital Self-Management and Peer Mentoring Intervention
Rutgers, The State University of New Jersey
Phase NA Enrolling by invitation
NCT07515274 2026-04-13
EQUICAP
Centre Leon Berard
Phase NA Not yet recruiting
NCT01706939 2026-04-09
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Icahn School of Medicine at Mount Sinai
Phase 3 Active not recruiting
NCT06790602 2026-04-09
SWITCH
University of California, San Diego
Phase 2 Recruiting
NCT07518797 2026-04-09
ASPIRE AI
Rabin Medical Center
Phase NA Not yet recruiting
NCT06745024 2026-04-08
Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial
NRG Oncology
Phase 3 Active not recruiting
NCT07284589 2026-04-08
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Nuclear Imaging Institute
Phase 2 Recruiting
NCT07346209 2026-04-08
STRIPe
University of California, San Diego
Phase 2 Not yet recruiting
NCT07517666 2026-04-08
GIFTT
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT06939452 2026-04-07
A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression
The First Affiliated Hospital of Zhengzhou University
Phase 2 Active not recruiting
NCT05407844 2026-04-06
DeCIDE PC
Wake Forest University Health Sciences
Phase NA Enrolling by invitation
NCT05784766 2026-04-06
SARIC
University of Oklahoma
Phase NA Active not recruiting
NCT06152523 2026-04-06
MONAMI
Assistance Publique - Hôpitaux de Paris
Phase 2 Withdrawn
NCT06699615 2026-04-06
Assessing Perceptions of ML Explanations by Medical Oncologists
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT07511023 2026-04-06
Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT04309578 2026-04-03
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
Phase 2 Completed
NCT04824859 2026-04-03
eGAP
University of Rochester
Phase NA Terminated
NCT04981821 2026-04-03
GO-EXCAP2
University of Rochester
Phase NA Recruiting
NCT05356182 2026-04-03
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
State University of New York at Buffalo
Phase NA Recruiting
NCT06237816 2026-04-03
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
University of Hawaii
Phase NA Recruiting
NCT06630845 2026-04-03
Comparison of Whole Body DWI to FDG PET
University of California, San Francisco
Phase NA Recruiting
NCT07144085 2026-04-03
Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.
First Hospital of China Medical University
Phase 1 Recruiting
NCT04713046 2026-04-02
Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Active not recruiting
NCT07481890 2026-04-02
Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients.
Lega Cancro Ticino
Phase NA Recruiting
NCT03432936 2026-04-01
Prospective Use of Philips iSuite for Interventional Procedures
Mayo Clinic
Phase NA Enrolling by invitation
NCT06296641 2026-04-01
Cope-CAYAC
Columbia University
Phase NA Enrolling by invitation
NCT06560398 2026-04-01
ACT WONDER²S
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Recruiting
NCT06926972 2026-04-01
NOURISH
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Active not recruiting
NCT07435597 2026-04-01
Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients
Atlas University
Phase NA Recruiting